SMALL CELL LUNG CANCER ( SCLC )
Clinical trials for SMALL CELL LUNG CANCER ( SCLC ) explained in plain language.
Never miss a new study
Get alerted when new SMALL CELL LUNG CANCER ( SCLC ) trials appear
Sign up with your email to follow new studies for SMALL CELL LUNG CANCER ( SCLC ), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental combo aims to tackle Treatment-Resistant cancers
Disease control Not yet recruitingThis early-stage trial tests whether an experimental drug called TLN-499, combined with the approved cancer drug venetoclax, is safe and tolerable for people with certain advanced solid tumors that have stopped responding to standard treatments. The study includes adults with sma…
Matched conditions: SMALL CELL LUNG CANCER ( SCLC )
Phase: PHASE1 • Sponsor: Treeline Biosciences, Inc. • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Can a gentler drug trio tame small cell lung cancer in older patients?
Disease control Not yet recruitingThis trial is testing a combination of three drugs—benmelstobart, anlotinib, and etoposide—as a first treatment for elderly patients (65 and older) or those too frail for standard intensive chemotherapy. The goal is to see if this platinum-free regimen can control the cancer and …
Matched conditions: SMALL CELL LUNG CANCER ( SCLC )
Phase: PHASE3 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Engineered immune cells take on tough cancers in first human trial
Disease control Not yet recruitingThis early-phase trial tests a new treatment called ML261 for people with advanced small cell lung cancer or certain neuroendocrine cancers that have not responded to standard treatments. ML261 is made from a patient's own immune cells, which are modified in a lab to better recog…
Matched conditions: SMALL CELL LUNG CANCER ( SCLC )
Phase: PHASE1 • Sponsor: Moonlight Bio, Inc • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New drug combo aims to tame tough lung cancer
Disease control Not yet recruitingThis study tests a new drug combination (alisertib plus paclitaxel) in people with small cell lung cancer who have already tried other treatments. The main goal is to find safe doses and see what side effects occur. About 50 adults will take alisertib pills and receive paclitaxel…
Matched conditions: SMALL CELL LUNG CANCER ( SCLC )
Phase: PHASE2 • Sponsor: Puma Biotechnology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Could a 50-Year-Old antipsychotic drug shrink Hard-to-Treat cancers?
Disease control Not yet recruitingThis study tests penfluridol, a drug originally used for mental health, in 33 adults with small cell lung or cervical cancer that has returned after at least two prior treatments. The goal is to see if the drug can shrink tumors or slow disease progression. Participants take the …
Matched conditions: SMALL CELL LUNG CANCER ( SCLC )
Phase: PHASE1, PHASE2 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC